Soleno Therapeutics Inc (SLNO) with a beta value of -2.52 appears to be a promising investment opportunity.
Soleno Therapeutics Inc (NASDAQ: SLNO) kicked off on Thursday, up 0.07% from the previous trading day, before settling in for the closing price of $69.93.